Prolactinomas express human heparin-binding secretory transforming gene (hst) protein product: Marker of tumour invasiveness

Clinical Endocrinology

Volumn 48, Issue 1, 1998, Pages 23-29

  Shimon, Ilan ^a   Hinton, David R ^b   Weiss, Martin H ^b   Melmed, Shlomo ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN BINDING PROTEIN;

ALLELE; ARTICLE; CANCER INVASION; CELL PROLIFERATION; CELL STIMULATION; GENE EXPRESSION REGULATION; GENE MUTATION; HUMAN; HUMAN TISSUE; HYPOPHYSIS CELL; IMMUNOREACTIVITY; POINT MUTATION; PRIORITY JOURNAL; PROLACTINOMA; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ADRENOCORTICOTROPIC HORMONE; ADULT; FEMALE; FIBROBLAST GROWTH FACTOR 4; FIBROBLAST GROWTH FACTORS; GROWTH HORMONE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; NEOPLASM INVASIVENESS; PITUITARY GLAND, ANTERIOR; PITUITARY NEOPLASMS; PROLACTINOMA; PROTO-ONCOGENE PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 0031914544     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1998.00332.x     Document Type: Article

References (37)

1. Adelaide, J., Mattei, M.G., Marics, I., Raybaud, F., Planche, J., Lapeyriere, O.D. & Biranbaum, D. (1988) Chromosomal localization of the hst oncogene and its co-amplification with the int.2 oncogene in human melanoma. Oncogene, 2, 413-416.
2. Alexander, J.M., Biller, B.M., Bikkai, H., Zervas, N.T., Arnold, A. & Klibanski, A. (1990) Clinically nonfunctioning pituitary tumors are monoclonal in origin. Journal of Clinical Investestigation, 86, 336-340.
3. Boggild, M.D., Jenkinson, S., Pistorello, M., Boscaro, M., Scanarini, M., McTernan, P., Perrett, C.W., Thakker, R.V. & Clayton, R.N. (1994) Molecular genetic studies of sporadic pituitary tumors. Journal of Clinical Endocrinology and Metabolism, 78, 387-392.
4. Bohlen, P., Baird, A., Esch, F., Ling, N. & Gospodarowicz, D. (1984) Isolation and partial molecular characterization of pituitary fibroblast growth factor. Proceedings of the National Academy of Science USA, 81, 5364-5368.
5. Brooks, S., Smith, R., Thurlow, J., Dickson, C. & Peters, G. (1989) The mouse homologue of hst/K-FGF: sequence, genome organization and location relative to int-2. Nucleic Acids Research, 17, 4037-4045.
6. Bystrom, C., Larsson, C., Blomberg, C., Sandelin, K., Falkmer, U., Skogseid, B., Oberg, K., Werner, S. & Nordenskjold, M. (1990) Localization of the MEN1 gene to a small region whithin chromosome 11q13 by deletion mapping in tumors. Proceedings of the National Academy of Science USA, 87, 1968-1972.
7. Delli Bovi, P. & Basilico, C. (1987) Isolation of a rearranged human transforming gene following transfection of Kaposi sarcoma DNA. Proceedings of the National Academy of Science USA, 84, 5660-5664.
8. Delli Bovi, P., Curatola, A.M., Kern, F.G., Greco, A., Ittman, M. & Basilico, C. (1987) An oncogene isolated by transfection of Kaposi's sarcoma DNA encodes a growth factor that is a member of the FGF family. Cell, 50, 729-737.
9. Dong, Q., Brucker-Davis, F., Weintraub, B.D., Smallridge, R.C., Carr, F.E., Battey, J., Spiegel, A.M. & Shenker, A. (1996) Screening of candidate oncogenes in human thyrotroph tumors: absence of activating mutations of the G (q, G (11, G (s, or thyrotropin-releasing hormone receptor genes. Journal of Clinical Endocrinology and Metabolism, 81, 1134-1140.
10. Elias, K.A. & Weiner, R.I. (1984) Direct arterial vascularization of estrogen-induced prolactin-secreting anterior pituitary tumors. Proceedings of the National Academy of Science USA, 81, 4549-4553.
11. Ezzat, S., Smyth, H.S., Ramyar, L. & Asa, S.L. (1995) Heterogenous in vivo and in vitro expression of basic fibroblast growth factor by human pituitary adenomas. Journal of Clinical Endocrinology and Metabolism, 80, 878-884.
12. Faccenda, E., Melmed, S., Bevan, J.S. & Eidne, K.A. (1996) Structure of the thyrotrophin-releasing hormone receptor in human pituitary adenomas. Clinical Endocrinology, 44, 341-347.
13. Feldman, B., Poueymirou, W., Papaioannou, V.E., DeChiara, T.M. & Goldfarb, M. (1995) Requirement of FGF-4 for postimplantation mouse development. Science, 267, 246-249.
14. Friedman, E., Adams, E.F., Hoog, A., Gejman, P.V., Carson, E., Larsson, C., De Marco, L., Werner, S., Fahlbusch, R. & Nordenskjold, M. (1994) Normal structural dopamine type 2 receptor gene in prolactin-secreting and other pituitary tumors. Journal of Clinical Endocrinology and Metabolism, 78, 568-574.
15. Gonsky, R., Herman, V., Melmed, S. & Fagin, J. (1991) Transforming DNA sequences present in human prolactin secreting pituitary tumors. Molecular Endocrinology, 5, 1687-1695.
16. Herman, V., Drazin, N.Z., Gonsky, R. & Melmed, S. (1993) Molecular screening of pituitary adenomas for gene mutations and rearrangements. Journal of Clinical Endocrinology and Metabolism, 77, 50-55.
17. Herman, V., Fagin, J., Gonsky, R., Kovacs, K. & Melmed, S. (1990) Clonal origin of secretory and non-secretory pituitary adenomas. Journal of Clinical Endocrinology and Metabolism, 71, 1427-1433.
18. Karga, H.J., Alexander, J.M., Hedley-Whyte, E.T., Klibansky, A. & Jameson, J.L. (1992) Ras mutations in human pituitary tumors. Journal of Clinical Endocrinology and Metabolism, 74, 914-919.
19. Landis, C.A., Masters, S.B., Spada, A., Pace, A.M., Bourne, H.R. & Vallar, L. (1989) GTPsae inhibiting mutations activate the (chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature, 340, 692-696.
20. Li, Y., Koga, M., Kasayama, S., Matsumoto, K., Arita, N., Hayakawa, T. & Sato, B. (1992) Identification and characterization of high molecular weight forms of basic fibroblast growth factor in human pituitary adenomas. Journal of Clinical Endocrinology and Metabolism, 75, 1436-1441.
21. Mason, I.J. (1994) The ins and outs of fibroblast growth factors. Cell, 78, 547-552.
22. Pegolo, G., Buckwalter, J.G., Weiss, M.H. & Hinton, D.R. (1995) Pituitary adenomas: correlation of the cytologic appearance with biological behavior. Acta Cytologia, 39, 887-892.
23. Pei, L., Melmed, S., Scheithauer, B., Kovacs, K. & Prager, D. (1994) H-ras mutations in human pituitary carcinoma metastasis. Journal of Clinical Endocrinology and Metabolism, 78, 842-846.
24. Ray, D. & Melmed, S. (1997) Pituitary cytokine and growth factor expression and action. Endocrine Reviews, 18, 206-228.
25. Sakamoto, H., Mori, M., Taira, M., Yoshida, T., Matsukawa, S., Shimizu, K., Sekiguchi, M., Terada, M. & Sugimura, T. (1986) Transforming gene from human stomach cancers and a noncancerous portion of stomach mucosa. Proceedings of the National Academy of Science USA, 83, 3997-4001.
26. Schechter, J., Goldsmith, P., Wilson, C. & Weiner, R. (1988) Morphological evidence for the presence of arteries in human prolactinomas. Journal of Clinical Endocrinology and Metabolism, 67, 713-719.
27. Shimon, I., Huttner, A., Said, J., Spirina, O.M. & Melmed, S. (1996) Heparin-binding secretory transforming gene (hst) facilitates rat lactotrope cell tumorigenesis and induces prolactin gene transcription. Journal of Clinical Investigation, 97, 187-195.
28. Shimon, I. & Melmed, S. (1997) Genetic basis of endocrine disease: pituitary tumour pathogenesis. Journal of Clinical Endocrinology and Metabolism, 82, 1675-1681.
29. Sippy, B.D., Hofman, F.M., Wallach, D. & Hinton, D.R. (1995) Increased expression of tumor necrosis-a receptors in the brain of patients with AIDS. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 10, 511-521.
30. Taira, M., Yoshida, T., Miyagawa, K., Sakamoto, H., Terada, M. & Sugimura, T. (1987) cDNA sequence of human transforming gene hst and identification of the coding sequence required for transforming activity. Proceedings of the National Academy of Science USA, 84, 2980-2984.
31. Thakker, R.V., Pook, M.A., Wooding, C., Boscaro, M., Scanarini, M. & Clayton, R.N. (1993) Association of somatotrophinomas with loss of alleles on chromosome 11 and with gsp mutations. Journal of Clinical Investigation, 91, 2815-2821.
32. Thapar, K., Kovacs, K., Scheithauer, B.W., Stefaneanu, L., Horvath, E., Pernicone, P.J., Murray, D. & Laws, E.R. Jr (1996) Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an anlysis using the MIB-1 antibody. Neurosurgery, 38, 99-107.
33. Tordjman, K., Stern, N., Ouaknine, G., Yossiphov, Y., Razon, N., Nordenskjold, M. & Friedman, E. (1993) Activating mutations of the Gs (-gene in nonfunctioning pituitary tumors. Jornal of Clinical Endocrinology and Metabolism, 77, 765-769.
34. Velcich, A., Delli Bovi, P., Mansukhani, A., Ziff, E.B. & Basilico, C. (1989) Expression of the K-fgf protooncogene is repressed during differentiation of F9 cells. Oncogene Research, 5, 31-37.
35. Yoshida, T., Ishimaru, K., Sakamoto, H., Yokota, J., Hirohashi, S., Igarashi, K., Sudo, K. & Terada, M. (1994) Angiogenic activity of recombinant hst-1 protein. Cancer Letter, 83, 261-268.
36. Yoshida, T., Miyagawa, K., Odagiri, H., Sakamoto, H., Little, P.F., Terada, M. & Sugimura, T. (1987) Genomic sequence of hst, a transforming gene encoding a protein homologous to fibroblast growth factors and the int-2-encoded protein. Proceedings of the National Academy of Science USA, 84, 7305-7309.
37. Yoshida, M.C., Wada, M., Satoh, H., Yoshida, T., Sakamoto, H., Miyagawa, K., Yokota, J., Koda, T., Kakinuma, M., Sugimura, T. & Terada, M. (1988) Human HST1 (HSTF1) gene maps to chromosome band 11q13 and coamplifies with the INT2 gene in human cancer. Proceedings of the National Academy of Science USA, 85, 4861-4864.